In this study, treatment with an anti-CCL2 antibody alone was not found to have a cytotoxic effect on neuroblastoma cells, which supports that the mechanism of action is via CCR2, the primary receptor for CCL2. This evidence concerns the gene CCL2 and neuroblastoma.